A randomized, placebo-controlled study of donepezil in poststroke aphasia

Marcelo L. Berthier, C. Green, Carolina Higueras, Inmaculada Fernández, Julían Hinojosa, M Carmona Martín

Neurology · 2006 · 138 citations · 3 references

Concepts

Abstract

We studied 26 patients in a randomized, placebo-controlled, double-blind parallel trial to evaluate the efficacy and safety of donepezil in chronic poststroke aphasia. Donepezil (10 mg/day) improved aphasia severity at endpoint (week 16) relative to placebo (p = 0.037).

References

3